About Goldenseal
Goldenseal (Hydrastis canadensis) root contains 2–5% isoquinoline alkaloids — primarily berberine, with hydrastine and canadine. Most marketing claims (antimicrobial, immune support, GI infection) extrapolate from berberine research; crude goldenseal at typical supplement doses delivers small berberine quantities (often <50 mg) far below the 1000–1500 mg/day used in berberine RCTs. Hydrastine and canadine add modest pharmacology but lack their own clinical evidence. SAFETY: avoid in pregnancy — berberine displaces bilirubin from albumin and can cause kernicterus in newborns. Hyperbilirubinemia risk in neonates via breast milk. CYP3A4/CYP2D6 inhibition is meaningful at higher doses — drug interaction caution. Conservation status: wild goldenseal is CITES Appendix II listed due to overharvesting; cultivated sourcing strongly preferred. The herb has been overhyped on the doctrine of folk-medicine 'cure-all' positioning for over a century — most claims do not survive RCT scrutiny.
What Goldenseal supports
- Contains berberine — most goldenseal claims extrapolate from berberine research, not whole-root trials
- Avoid in pregnancy and breastfeeding — kernicterus risk in newborns
How much Goldenseal to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
250–1000
mg
Traditional dosing range delivers ~12–50 mg berberine at 5% standardization. Standardized berberine HCl (500–1500 mg/day) has much stronger evidence than crude goldenseal; sub-500 mg whole-root doses likely deliver sub-clinical berberine levels.
Clinical evidence
Limited clinical evidence. Whole-root RCT evidence is sparse; clinical claims piggyback on berberine literature without delivering equivalent berberine doses.
Reference